Masimo (MASI) Net Cash Flow Growth (5y) (2014 - 2026)
Masimo (MASI) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 21.24% |
| Sep 27, 2025 | -45.22% |
| Jun 28, 2025 | -1.53% |
| Mar 29, 2025 | -16.39% |
| Dec 28, 2024 | 3.04% |
| Sep 28, 2024 | -15.95% |
| Jun 29, 2024 | -10.24% |
| Mar 30, 2024 | 15.01% |
| Dec 30, 2023 | -19.66% |
| Sep 30, 2023 | -16.64% |
| Jul 1, 2023 | -15.55% |
| Apr 1, 2023 | -23.25% |
| Dec 31, 2022 | -27.54% |
| Oct 1, 2022 | 22.28% |
| Jul 2, 2022 | -105.77% |
| Apr 2, 2022 | -21.41% |
| Jan 1, 2022 | -81.38% |
| Apr 3, 2021 | -73.08% |
| Mar 28, 2020 | 60.73% |
| Sep 28, 2019 | 35.49% |